Search Results - "Mando, Pablo"

The BA-BCS 2021: An Initial “Trial” for Integrating Basic Science and Medical Progress on Breast Cancer in a Latin-American Country by Kordon, Edith, Lanari, Claudia, Mando, Pablo, Novaro, Virginia, Rossi, Mario, Simian, Marina

“…The first Buenos Aires Breast Cancer Symposium (BA-BCS) was held in a virtual format, between the 17 th and the 21 st of May 2021. The main goal of the meeting…”
Get full text

Higher risk of recurrence in early-stage breast cancer patients with increased levels of ribosomal protein S6 by Cascardo, Florencia, Vivanco, Micaela, Perrone, María Cecilia, Werbach, Andrea, Enrico, Diego, Mando, Pablo, Amat, Mora, Martínez-Vazquez, Paula, Burruchaga, Javier, Mac Donnell, María, Lanari, Claudia, Zwenger, Ariel, Waisberg, Federico, Novaro, Virginia

“…PI3K/AKT/mTOR pathway is implicated in breast cancer progression and recurrence. The identification of PIK3CA and AKT1 mutations and loss of PTEN serve as…”
Get full text

Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients by Bordignon, María B., Pesce Viglietti, Ayelén I., Juliá, Estefanía P., Sanchez, María B., Rölle, Alexander, Mandó, Pablo, Sabatini, Luciana, Ostinelli, Alexis, Rizzo, Manglio M., Barrio, María M., Mordoh, José, Fainboim, Leonardo, Levy, Estrella M.

“…Adaptive NK cells constitute an NK cell subpopulation, which expands after human cytomegalovirus (HCMV) infection. This subpopulation has stronger production…”
Get full text

LuciA-15 - a real-world prospective study of PARP inhibitors for the treatment of patients with HER-2 negative metastatic breast cancer with germline and/or somatic mutation of BRCA genes or homologous recombination repair related genes by Petracci, Fernando E, Villarreal-Garza, Cynthia, Argañaraz, Facundo, Abuin, Gonzalo Gómez, Peñaloza, José, Flores, Marcos Ariel, Piazzoni, Luciano, Riggi, Cecilia, Fabiano, Lucía, González, Lucía, Cieplinski, Belén, Rivero, Sergio, Korbenfeld, Ernesto, Mandó, Pablo

“…Poly(adenosine diphosphate-ribose) polymerase inhibitors (PARPi) improve progression free survival among patients with HER2 negative (HER2-ve) advanced breast…”
Get full text

High neutrophil to lymphocyte ratio and decreased CD69 + NK cells represent a phenotype of high risk in early-stage breast cancer patients by Mandó, Pablo, Rizzo, Manglio, Roberti, María Paula, Juliá, Estefanía Paula, Pampena, María Betina, Pérez de la Puente, Constanza, Loza, Carlos Martín, Ponce, Carolina, Nadal, Jorge, Coló, Federico Andres, Mordoh, José, Levy, Estrella Mariel

“…Breast cancer (BC) is a highly heterogeneous disease presenting a broad range of clinical and molecular characteristics. In the past years, a growing body of…”
Get full text

Targeting ADCC: A different approach to HER2 breast cancer in the immunotherapy era by Mandó, Pablo, Rivero, Sergio G., Rizzo, Manglio M., Pinkasz, Marina, Levy, Estrella M.

“…The clinical outcome of patients with human epidermal growth factor receptor 2 (HER2) amplified breast carcinoma (BC) has improved with the development of…”
Get full text

Analysis of adverse events attribution and reporting in cancer clinical trials: A systematic review by Enrico, Diego, Waisberg, Federico, Burton, Jeannette, Mandó, Pablo, Chacón, Matías

“…[Display omitted] •Drug safety investigation is crucial in cancer clinical trials.•We reviewed adverse events (AEs) reporting and attribution process in…”
Get full text

Assessing the methodological quality of quality-of-life analyses in first-line non-small cell lung cancer trials: A systematic review by Waisberg, Federico, Lopez, Carlos, Enrico, Diego, Rodriguez, Andrés, Hirsch, Ian, Burton, Jeannette, Mandó, Pablo, Martin, Claudio, Chacón, Matias, Seetharamu, Nagashree

“…Non-cytotoxic therapy has changed the treatment paradigm for advanced non-small cell lung cancer (NSCLC) patients. With unique mechanisms of action, these…”
Get full text

In-Depth Analysis of the Peripheral Immune Profile of HER2+ Breast Cancer Patients on Neoadjuvant Treatment with Chemotherapy Plus Trastuzumab Plus Pertuzumab by Pesce Viglietti, Ayelén Ivana, Bordignon, María Belén, Ostinelli, Alexis, Rizzo, Manglio Miguel, Cueto, Gerardo, Sanchez, María Belén, Perazzo, Florencia, Amat, Mora, Coló, Federico, Costanzo, María Victoria, Nervo, Adrián, Nadal, Jorge, Crimi, Gabriel, Mc Lean, Ignacio, Spengler, Eunice Amancay, Mordoh, José, Mandó, Pablo, Levy, Estrella Mariel

“…Currently, therapy for early-stage human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC) is based on the combination of trastuzumab and…”
Get full text

Peripheral changes in immune cell populations and soluble mediators after anti-PD-1 therapy in non-small cell lung cancer and renal cell carcinoma patients by Juliá, Estefanía Paula, Mandó, Pablo, Rizzo, Manglio Miguel, Cueto, Gerardo Rubén, Tsou, Florencia, Luca, Romina, Pupareli, Carmen, Bravo, Alicia Inés, Astorino, Walter, Mordoh, José, Martín, Claudio, Levy, Estrella Mariel

“…Patients with non-small cell lung cancer (NSCLC) and renal cell carcinoma (RCC) have shown benefit from anti-PD-1 therapies. However, not all patients…”
Get full text

Burnout syndrome in medical oncologists during the COVID-19 pandemic: Argentinian national survey by Guercovich, Andres, Piazzioni, Gonzalo, Waisberg, Federico, Mandó, Pablo, Angel, Martín

“…Burnout (BO) syndrome is a condition that results in physical and mental distress. The current COVID-19 pandemic is strongly affecting the mental health of the…”
Get full text

HER2-Directed Therapy in Advanced Breast Cancer: Benefits and Risks by Mandó, Pablo, Waisberg, Federico, Pasquinelli, Rosario, Rivero, Sergio, Ostinelli, Alexis, Perazzo, Florencia

“…Around 20% of breast cancers are associated with amplification or overexpression of human epidermal growth factor receptor 2 (HER2). In this setting,…”
Get full text

Prevalence of hepatitis E virus in children from Northeast of Argentina by Martínez, Alfredo P., Pereson, Matías J., Pérez, Paula S., Baeck, María Inés, Mandó, Pablo, López Saubidet, Ignacio, Di Lello, Federico A.

“…The aim of this study was to assess the prevalence of hepatitis E virus (HEV) in a young population from the Northeast region of Argentina. Four hundred and…”
Get full text

Breast Cancer in Young Women Presents With More Aggressive Pathologic Characteristics: Retrospective Analysis From an Argentine National Database by Fabiano, Verónica, Mandó, Pablo, Rizzo, Manglio, Ponce, Carolina, Coló, Federico, Loza, Martín, Loza, Jose, Amat, Mora, Mysler, Daniel, Costanzo, María Victoria, Nervo, Adrián, Nadal, Jorge, Perazzo, Florencia, Chacón, Reinaldo

“…Multiple studies have reported that breast cancer in young patients is associated with aggressive characteristics, and it is suggested that prognosis is worse…”
Get full text

Determining Clinicopathologic Factors That Influence Treatment in Advanced Breast Cancer in Argentina After CDK4/6 Inhibitors by Waisberg, Federico, Mandó, Pablo, Almada, Carolina, Kassis, Naima, Mainella, Andrea, Cermignani, Luciano, Riggi, María Cecilia, Winocur, Melina, González, Ramiro, Guercovich, Andres, Ayala, Natalia, Micheri, Cristian, Ituarte, Ana Carolina, González Mattos, Lucía, Llugdar, Pamela, Casalnuovo, Mónica, Lutteral, Maribel, Cinquini, Sebastián, Mazzotta, Alejandro, Lara Alcantara, Janeth, Penayo, Rosa, Gomez-Abuin, Gonzalo

“…The optimal treatment sequence for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) after…”
Get full text

Lack of Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Early Breast Cancer by Sifón, Maria del Rosario, Marcolini, Nicolas, Barber, Maria Julia, Mclean, Ignacio, Rizzo, Manglio, Rivero, Sergio, Costanzo, Maria Victoria, Nervo, Adrian, Crimi, Gabriel, Perazzo, Florencia, Levy, Estrella Mariel, Mandó, Pablo

“…Background: Breast cancer is a highly heterogeneous disease with large differences in the risk of recurrence. An elevated neutrophil-to-lymphocyte ratio (NLR)…”
Get full text

A Theoretical View of Ovarian Cancer Relapse by Giornelli, Gonzalo H., Mandó, Pablo

“…Ovarian cancer (OC) is a disease that almost invariably relapses even after optimal primary cytoreductive surgery and standard first-line platinum-based…”
Get full text

Appraising the quality of meta-analysis for breast cancer treatment in the adjuvant setting: A systematic review by Mandó, Pablo, Hirsch, Ian, Waisberg, Federico, Ostinelli, Alexis, Luca, Romina, Pranevicene, Belen, Ferreyra Camacho, Augusto, Enrico, Diego, Chacon, Matías

“…•Methodological quality of early breast cancer adjuvant treatment is highly variable.•Correlations between journal impact factor or citation rate and AMSTAR…”
Get full text

High Histologic Grade and High Ki-67 Expression Predict Phenotypic Alterations in Node Metastasis in Primary Breast Cancers by Mandó, Pablo, Rizzo, Manglio, de la Puente, Constanza Perez, Maino, Mercedes, Ponce, Carolina, Pombo, Maria Teresa, Amat, Mora, Costanzo, Maria Victoria, Nervo, Adrian, Nadal, Jorge, Fabiano, Veronica, Loza, Jose, Loza, Carlos Martin, Colo, Federico, Reinaldo, Chacon

“…Several studies have shown that estrogen receptor (ER) and progesterone receptor (PR) expression and human epidermal growth factor receptor 2 (HER2) expression…”
Get full text

Predictive Factors for Non-Sentinel Lymph Node Metastasis in Patients with ACOSOG Z0011 Criteria by Loza, Carlos Martin, Mandó, Pablo, Ponce, Carolina, Coló, Federico, Fabiano, Veronica, Loza, Jose, Costanzo, Maria Victoria, Nervo, Adrian, Nadal, Jorge, Nuñez de Pierro, Anibal, Chacon, Reinaldo

“…Background: Nodal staging constitutes an element of great importance in the treatment planning for early breast cancer. The ACOSOG Z0011 trial demonstrated…”
Get full text